Streetbeat News

Analyst Ratings

UNM

Unum Gr (NYSE:UNM) reported Q2 adjusted earnings of $2.06 per share, beating the analyst consensus estimate of $1.87 by 10.16%. This is an increase from $1.92 per share from the same period last year. The company also reported quarterly sales of $3.11 billion, beating the analyst consensus estimate of $3.07 billion by 1.37%. This is a 2.33% increase from sales of $3.04 billion the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 10:26 am

TX

Ternium (NYSE:TX) reported Q2 earnings of $3.19 per share, beating the analyst consensus estimate of $1.96 by 62.76%. However, this is a 21.62% decrease from the same period last year. The company's quarterly sales of $3.87 billion missed the analyst consensus estimate of $3.88 billion by 0.23%, marking a 12.78% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 10:25 am

VREX

Varex Imaging (NASDAQ:VREX) reported Q3 earnings of $0.37 per share, beating the analyst consensus estimate of $0.33 by 12.12%. The company also reported quarterly sales of $232.20 million, surpassing the analyst consensus estimate of $229.90 million by 1.00%. This represents an 8.25% increase over sales of $214.50 million in the same period last year.

Portfolio Pulse from totan@benzinga.com

August 04, 2023 | 10:23 am

ALIT

Alight (NYSE:ALIT) reported Q2 earnings of $0.14 per share, beating the analyst consensus estimate of $0.12 by 16.67%. The company also reported quarterly sales of $806.00 million, surpassing the analyst consensus estimate of $796.54 million by 1.19%. Both earnings and sales show an increase compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 10:23 am

SE

A whale investor has taken a bullish stance on Sea (NYSE:SE), with 71% of the investors opening trades with bullish expectations and 28% with bearish. The trades include 2 puts for a total amount of $425,800 and 12 calls for a total amount of $720,288. The price target for Sea over the last 3 months ranges from $45.0 to $105.0. UBS has upgraded its action to Buy with a price target of $86.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 10:23 am

ANET

META

Arista Networks (ANET) has shown strong growth in 2Q23, driven by a surge in enterprise demand. Analysts from Keybanc, Needham, JMP Securities, and Morgan Stanley have maintained positive ratings and raised their price targets for ANET. The company's growth is attributed to its expanding opportunities with Cloud Titans, CSPs, and Enterprise, including AI-related expansion. However, one of its significant customers, believed to be Meta Platforms (META), reduced capex spending, slowing cloud titan deployments.

Portfolio Pulse from Anusuya Lahiri

August 04, 2023 | 10:22 am

CVS

A significant bullish stance has been taken on CVS Health (NYSE:CVS) by a large investor, as indicated by unusual options trading activity. The sentiment among these big-money traders is 71% bullish and 28% bearish. The targeted price range for CVS Health over the last 3 months is from $35.0 to $90.0. Analysts from JP Morgan, Barclays, and Mizuho have maintained their positive ratings on CVS Health, with price targets of $106, $89, and $88 respectively.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 10:22 am

ANDE

Andersons (NASDAQ:ANDE) reported Q2 earnings of $1.52 per share, beating the analyst consensus estimate of $1.06 by 43.4%. However, this is a 35.59% decrease from the same period last year. The company's quarterly sales of $4.02 billion missed the analyst consensus estimate of $4.15 billion by 3.20%, marking a 9.68% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 10:21 am

SEDG

SolarEdge Technologies reported Q2 adjusted earnings of $2.62 per share, beating the analyst consensus estimate of $2.55 by 2.75%. This is a 175.79% increase from the same period last year. The company also reported quarterly sales of $991.30 million, beating the analyst consensus estimate of $989.17 million by 0.22%. This is a 36.21% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 10:19 am

RIGL

Rigel Pharmaceuticals reported Q2 earnings per share of $(0.04), beating the analyst consensus estimate of $(0.08) by 50%. The company also reported quarterly sales of $26.89 million, beating the analyst consensus estimate of $26.02 million by 3.33%. However, this represents a 9.84% decrease in sales compared to the same period last year.

Portfolio Pulse from mahesh@benzinga.com

August 04, 2023 | 10:19 am